How it works
In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Erlotinib blocks this signal, and thus stops the production of these cancer cells.
Common side effects
Nausea, Vomiting, Fatigue, Breathing difficulty, Abdominal pain, Edema, Weight loss, Loss of appetite, Anemia, Infection, Bone pain, Constipation, Diarrhoea, Fever, Stomatitis (Inflammation of the mouth), Rash